Lung Cancer Surgery Market overview & Analysis of Key Players: Endoscopic Products, Ethicon Inc. (J & J), Medtronic Plc., Germed USA Inc. & Teleflex Incorporated, 2022-2029
Over 2 million new cases of lung cancer were registered globally by the end of 2021, as reported by the American Cancer Society, Inc. The global lung cancer surgery landscape currently represents a US$ 1 Bn market and will expand at a strong CAGR during the period of projection, 2022 - 2029. A new Future Market Insights (FMI) report states that the use of techniques that are minimally invasive, video assisted, and robot assisted is growing, which is shaping the future of lung cancer surgery market.
Robotic thoracic surgery would remain highly preferred over
traditional surgical techniques, as it offers higher magnification, more
precision, and eliminate the need for large-incision operations. Development of
new surgical robots may cut down the cost of devices and increase shift towards
robotic lung cancer surgery. Introduction of new imaging techniques for
enhancing visualization, angled lenses for enhanced accessibility, and end
staplers will continue to enhance the video-assisted lung cancer surgery
procedure.
Get the Report
Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-396
Intuitive Surgical is the sole player in robotic lung cancer
surgery market with its DaVinci system. Medtronic and Johnson & Johnson are
developing surgical robots and are challenging the monopoly of Intuitive
Surgical in lung cancer surgery market.
Key Takeaways - Lung Cancer Surgery Market Study
- Introduction
of powered and tissue-specific endoscopic stapling technology provides
significant benefits to reduce cost, resource usage, improve clinical
outcome compared to manual staplers.
- In
September 2022, Johnson & Johnson launched ECHELON CIRCULAR™ Powered
Stapler for thoracic, colorectal, and gastric surgery.
- In
March 2016, Intuitive Surgical Inc. got U.S. FDA approval for its da
Vinci Xi Endowrist Stapler 30 (30 mm) instruments and reloads.
- Key
market players are focusing on the development of new robot-assisted
thoracic surgery system. Partnerships & collaborations with best in
class surgical device and visualization technology developers are the
strategic focus of manufacturers. For instance,
- Medtronic
partnered with Karl Stroz, a best in class endoscopic imaging devices
manufacturer. In June 2022, Medtronic announced its upcoming
robotic-assisted surgical platform including three-dimensional vision
systems from Karl Stroz.
- East
Asia is expected to be the prominent region in the lung cancer surgery
market during the forecast year. This is attributed to high prevalence of
lung cancer in China & Japan increasing the demand for lung cancer
surgery. According to the International Agency for Research on Cancer,
from overall cancer patients in China and Japan, around 18.1% and 16.8%
patients respectively were having lung cancer.
Development in robotic thoracic surgery platforms and
innovation in tissue-specific endoscopic stapling and vessel sealing techniques
to reduce endoleak complications will further broaden the growth prospects of
the lung cancer surgery market.
Product Portfolio Expansion to Increase Global Footprint
Manufacturers are adopting product portfolio expansion
strategy to increase their footprint in the global lung cancer surgery market.
Market players such as Pentax Medical, Olympus, Johnson & Johnson,
Intuitive Surgical Inc. are continuously focusing on new product launches and
regulatory approvals. For instance,
- In
July 2016, PENTAX Medical launched new DEFINA high-definition pulmonology
endoscopy system for crystal clear imaging during surgical procedures.
- In
April 2018, Intuitive Surgical Inc. received U.S. FDA clearance for da
Vinci Vessel Sealer Extend single-use, the fully wristed bipolar
electrosurgical instrument for lung cancer surgery procedures such
lobectomy, segmentectomy, and wedge resection.
Learn More About Report
The lung cancer surgery market a new study from Future
Market Insights, provides unparalleled insights on evolution of the lung cancer
surgery market during 2014 – 2021 and presents demand projections during 2022 –
2029 on the basis of product type (thoracoscopes, mediastinoscopes,
bronchoscopes, robotic-assisted thoracic surgery systems, surgical staplers,
and surgical energy instruments), application (lobectomy, segmentectomy, wedge
resection, pneumonectomy), end user (hospitals, ambulatory surgical centers)
across seven prominent regions.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government,
investors, and associated audiences in the healthcare sector to
identify and accentuate vital aspects applicable to product strategy,
regulatory landscape, technology evolution, and other crucial issues to achieve
sustainable success. Our unique approach to gathering market intelligence
equips you in devising innovation-driven trajectories for your business. Know
more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market
intelligence and consulting services, serving clients in over 150 countries.
FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and
India. FMI's latest market research reports and industry analysis
help businesses navigate challenges and make critical decisions with confidence
and clarity amidst breakneck competition. Our customized and syndicated
market research reports deliver actionable insights that drive sustainable
growth. A team of expert-led analysts at FMI continuously tracks emerging
trends and events in a broad range of industries to ensure that our clients
prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Comments
Post a Comment